Georgetown Has Developed Blood Tests to Predict Alzheimers
Itai Buenahora — March 15, 2014 — Life-Stages
A research team of scientists from Georgetown University have developed disease-predicting blood tests. The test is able to predict Alzheimer's disease three years in advance, with a 96 percent accuracy.
This process works by identifying ten chemicals in the blood that initiate the disease. These chemicals are then released to the nerve cell membranes break down, and is detected in the blood plasma. This predictability allows the devolvement of new treatments that can be implemented before any symptoms arise. While there are pre-existing tests to diagnose the disease, this is the first of it's kind predicting the onset.
A group of 500 people people, all over the age of 70, were given cognitive tests over a five year period; 28 of which developed Alzheimer's. The research team continues its advancements in the test and hope to soon be able to predict the onset of the illness 10-20 years in advance. This medical advancement is groundbreaking and is sure to help fight the future of this disease.
This process works by identifying ten chemicals in the blood that initiate the disease. These chemicals are then released to the nerve cell membranes break down, and is detected in the blood plasma. This predictability allows the devolvement of new treatments that can be implemented before any symptoms arise. While there are pre-existing tests to diagnose the disease, this is the first of it's kind predicting the onset.
A group of 500 people people, all over the age of 70, were given cognitive tests over a five year period; 28 of which developed Alzheimer's. The research team continues its advancements in the test and hope to soon be able to predict the onset of the illness 10-20 years in advance. This medical advancement is groundbreaking and is sure to help fight the future of this disease.
Trend Themes
1. Alzheimer's-predicting Blood Tests - Advancements in Alzheimer's-predicting blood tests have the potential to transform the way we detect and treat Alzheimer's disease.
2. Early Disease Detection - Early disease detection technologies are disrupting the medical industry with groundbreaking research developments.
3. Personalized Medicine - Personalized medicine is the next frontier for Alzheimer's treatment, as novel approaches to prediction and prevention help break down treatment barriers.
Industry Implications
1. Medical Diagnostics - The medical diagnostics industry is set for transformation by Alzheimer's-predicting blood tests, opening up a new avenue for disease prediction and personalized treatment.
2. Pharmaceuticals - The pharmaceutical industry is ripe for innovation with early disease detection, offering new and improved treatments that can tackle serious diseases such as Alzheimer's head-on.
3. Health Care - Healthcare providers stand to benefit from revolutionary disease-prediction blood tests, as more efficient and precise treatments pave the way for a new era of patient care.
1.5
Score
Popularity
Activity
Freshness
